Did Concentrix repurchase any shares in Q2 2026?

No. The company explicitly stated it did not repurchase any shares under its share repurchase program during the second quarter ended May 31, 2026, despite generating record quarterly operating cash flow of $257.9 million.

How much repurchase authorization remains?

As of May 31, 2026, Concentrix had $396.6 million in remaining share repurchase authorization. This represents the unused balance of a previously authorized program; no new authorization was announced in this filing.

Why would a company pause buybacks in a strong cash quarter?

Management may prioritize dividends, debt reduction, acquisitions, or simply hold fire during periods of market volatility or valuation uncertainty. Concentrix paid $0.36 per share quarterly dividend and generated substantial free cash flow, providing optionality for capital deployment.

What does 'remaining authorization' mean?

It is the unused dollar amount available under a previously approved share repurchase program. Once exhausted through actual repurchases or expiration, a company must seek new board authorization to resume buybacks.

Does this filing authorize a new buyback program?

No. This is an earnings announcement that discloses execution activity (or lack thereof) and the remaining balance of an existing program. It does not announce a new authorization or material amendment.

CNXC 8-K Filed 2026-06-29 Execution disclosure

Concentrix repurchase program inactive in Q2 2026, $396.6M remains authorized

No share repurchases in second quarter; $396.6M authorization balance disclosed in earnings announcement

Remaining$397M

MechanismNot specified

What the filing says

Concentrix Corporation (NASDAQ: CNXC) announced in its second quarter fiscal 2026 earnings release that it did not repurchase any shares under its share repurchase program during the three-month period ended May 31, 2026. The company disclosed that as of May 31, 2026, the remaining share repurchase authorization stood at $396.6 million.

The company generated strong cash generation in the quarter, with operating cash flow of $257.9 million and adjusted free cash flow of $242.3 million, providing substantial capacity for capital allocation. The company simultaneously maintained its quarterly dividend program, paying $0.36 per share on May 5, 2026, with a declared quarterly dividend of $0.36 per share payable August 4, 2026.

No new authorization was announced in this filing. The execution mechanism and timing of future repurchases under the existing authorization were not specified in the earnings announcement.

The Company did not repurchase any shares under its share repurchase program during the second quarter of fiscal year 2026. At May 31, 2026, the Company's remaining share repurchase authorization was $396.6 million. — Concentrix Corp 8-K filing · View on SEC EDGAR →

What this means

This filing documents execution activity rather than a new authorization or amendment. Concentrix held $396.6 million of existing repurchase authority but chose not to deploy it during Q2 2026, despite generating record quarterly operating cash flow of $257.9 million. The company instead prioritized its dividend, returning $0.36 per share quarterly to shareholders. The decision to pause buybacks in a strong cash-generation quarter may reflect management's capital allocation priorities or market conditions at the time. With approximately 60.9 million diluted shares outstanding (per Q3 guidance), the remaining authorization represents approximately 0.65% of current market equity, providing flexibility for opportunistic repurchases.

Frequently asked questions

Did Concentrix repurchase any shares in Q2 2026?: No. The company explicitly stated it did not repurchase any shares under its share repurchase program during the second quarter ended May 31, 2026, despite generating record quarterly operating cash flow of $257.9 million.
How much repurchase authorization remains?: As of May 31, 2026, Concentrix had $396.6 million in remaining share repurchase authorization. This represents the unused balance of a previously authorized program; no new authorization was announced in this filing.
Why would a company pause buybacks in a strong cash quarter?: Management may prioritize dividends, debt reduction, acquisitions, or simply hold fire during periods of market volatility or valuation uncertainty. Concentrix paid $0.36 per share quarterly dividend and generated substantial free cash flow, providing optionality for capital deployment.
What does 'remaining authorization' mean?: It is the unused dollar amount available under a previously approved share repurchase program. Once exhausted through actual repurchases or expiration, a company must seek new board authorization to resume buybacks.
Does this filing authorize a new buyback program?: No. This is an earnings announcement that discloses execution activity (or lack thereof) and the remaining balance of an existing program. It does not announce a new authorization or material amendment.

execution no-repurchase mega-cap remaining-authorization dividend cash-generation

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.